Traditionally, laboratories have to treat tissue with dyes to identify cells and detect any abnormalities. This process often takes several days and consumes part of the sample, sometimes to the detriment of other analyses. ClearStain represents a new generation of tools at the service of science and patients. This AI creates a digital version of the tissue in just a few minutes from a simple unstained slide. The image generated by the AI is so faithful that, according to studies carried out by Pictor Labs, it is judged by specialists to be 99% comparable to a real slide. In addition to saving time, this innovation offers a considerable advantage: preserving the original tissue. Scientists can now perform multiple analyses on the same sample, improving diagnostic accuracy and reducing the risk of error. " With ClearStain, cases that would have failed sequencing in the past can be saved," explains Megan Rothney, Vice President Product at Pictor Labs.
ClearStain is based on deep learning that transforms natural tissue light into images with the same precision as traditional slides. Presented for the first time at the Society for Immunotherapy of Cancer conference (the leading international gathering dedicated to advances in cancer immunotherapy) in Washington, ClearStain marks a turning point towards faster, more durable and accessible analyses.
